购物车
- 全部删除
- 您的购物车当前为空
Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively).
Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,820 | 35日内发货 | |
5 mg | ¥ 6,430 | 5日内发货 | |
10 mg | ¥ 8,670 | 5日内发货 |
产品描述 | Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively). |
靶点活性 | FGFR1:2.2 nM, PDGFRα:1.1 nM, c-Kit:12.5 nM, VEGFR2:1.5 nM |
别名 | AP24534 D8 |
分子量 | 540.61 |
分子式 | C29H27F3N6O |
CAS No. | 1562993-37-6 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容